HIGHLIGHTS
- who: Report and colleagues from the Takeda Hospital, Kyoto, JPN have published the article: Review began 03/23/2023 Review ended 04/08/2023 Published 04/18/2023 u00a9 Copyright, in the Journal: (JOURNAL) of April/18,/2023
- what: The authors report a case of ES-SCLC with prolonged survival of over 30 months, despite multiple recurrences following discontinued treatment with atezolizumab.
SUMMARY
Most patients diagnosed with extended-stage small cell lung cancer (ES-SCLC) have a poor prognosis, with conventional chemotherapies using cytotoxic agents offering a median survival of approximately . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.